LU5DF, Osvaldo Santarone (SINGLE-OP HIGH)
| 1 | 40m | CW | 2020-12-12 18:00:00 | LU5DF | GF02 | CX6DRA | GF15 | P=10 M=Uruguay |
| 2 | 40m | CW | 2020-12-12 18:02:00 | LU5DF | GF02 | LU1DJX | FF93 | P=10 |
| 3 | 40m | CW | 2020-12-12 18:04:00 | LU5DF | GF02 | LU7CRA | GF05 | P=10 M=CABA |
| 4 | 40m | CW | 2020-12-12 18:05:00 | LU5DF | GF02 | LW1EXU | GF15 | P=10 |
| 5 | 40m | CW | 2020-12-12 18:07:00 | LU5DF | GF02 | LU1DZ | GF05 | P=10 |
| 6 | 40m | CW | 2020-12-12 18:08:00 | LU5DF | GF02 | LU5UEA | FF84 | P=10 M=La Pampa |
| 7 | 40m | CW | 2020-12-12 18:12:00 | LU5DF | GF02 | LU3DO | GF13 | P=10 |
| 8 | 40m | CW | 2020-12-12 18:16:00 | LU5DF | GF02 | LU6EC | GF04 | P=10 |
| 9 | 40m | CW | 2020-12-12 18:18:00 | LU5DF | GF02 | LU3VAL | FF60 | P=10 M=Rio Negro |
| 10 | 40m | CW | 2020-12-12 18:19:00 | LU5DF | GF02 | LU1UG | FF84 | P=10 |
| 11 | 40m | CW | 2020-12-12 18:27:00 | LU5DF | GF02 | LU1VZ/V | FF60 | NIL |
| 12 | 40m | CW | 2020-12-12 18:31:00 | LU5DF | GF02 | LU3VAL | FF60 | P=10 |
| 13 | 40m | CW | 2020-12-12 18:33:00 | LU5DF | GF02 | LU6UAL | FF93 | Serie: FF73 |
| 14 | 40m | CW | 2020-12-12 18:35:00 | LU5DF | GF02 | LU6EC | GF04 | P=10 |
| 15 | 40m | CW | 2020-12-12 18:36:00 | LU5DF | GF02 | LU5UEA | FF84 | P=10 |
| 16 | 40m | CW | 2020-12-12 18:38:00 | LU5DF | GF02 | LU1DZ | GF05 | P=10 |
| 17 | 40m | CW | 2020-12-12 18:39:00 | LU5DF | GF02 | LU4VSD | FE48 | P=10 |
| 18 | 40m | CW | 2020-12-12 18:41:00 | LU5DF | GF02 | LU1DJX | FF93 | P=10 |
| 19 | 40m | CW | 2020-12-12 18:43:00 | LU5DF | GF02 | CX6DRA | GF15 | P=10 |
| 20 | 40m | CW | 2020-12-12 18:44:00 | LU5DF | GF02 | LU1UG | FF84 | P=10 |
| 21 | 40m | CW | 2020-12-12 18:50:00 | LU5DF | GF02 | LU7VB | FF61 | P=10 |
| 22 | 40m | CW | 2020-12-12 18:55:00 | LU5DF | GF02 | LU6UAL | FF93 | Serie: FF73 |
| 23 | 40m | CW | 2020-12-12 18:56:00 | LU5DF | GF02 | LU6UAL | FF93 | Serie: FF73 |
Resultado
| Puntos | 190 |
| Multiplicadores | 4 |
| Total | 760 |
| Tiempo | 56 min. (rate=24.64 QSOs/h) |
Descuento de Puntos
| NIL (Not in Log) | 4.35% |
| Error Serie Rx | 13.04% |